Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Net Cash Flow (2016 - 2026)

Apyx Medical filings provide 15 years of Net Cash Flow readings, the most recent being $6.7 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 86.7% to $6.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $465000.0, a 103.87% increase, with the full-year FY2025 number at $465000.0, up 103.87% from a year prior.
  • Net Cash Flow hit $6.7 million in Q4 2025 for Apyx Medical, up from -$4.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $21.5 million in Q4 2023 to a low of -$6.4 million in Q1 2024.
  • Median Net Cash Flow over the past 5 years was -$3.1 million (2021), compared with a mean of -$506450.0.
  • Biggest five-year swings in Net Cash Flow: crashed 2882.17% in 2022 and later skyrocketed 560.04% in 2023.
  • Apyx Medical's Net Cash Flow stood at -$157000.0 in 2021, then crashed by 2882.17% to -$4.7 million in 2022, then skyrocketed by 560.04% to $21.5 million in 2023, then tumbled by 83.39% to $3.6 million in 2024, then surged by 86.7% to $6.7 million in 2025.
  • The last three reported values for Net Cash Flow were $6.7 million (Q4 2025), -$4.0 million (Q3 2025), and -$1.5 million (Q2 2025) per Business Quant data.